Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Nevro Corp. (NYSE: NVRO) has granted inducement restricted stock unit awards to 24 new non-executive employees. The awards, covering 37,726 shares of Nevro's common stock, were granted on November 7, 2024, under the company's 2023 Inducement Award Plan. These grants, approved by the Compensation Committee of Nevro's Board of Directors, will vest over a three-year period, contingent on continued employment. The awards were issued in accordance with NYSE Listed Company Manual Rule 303A.08 as material inducements to employment.
Nevro Corp. (NYSE: NVRO) ha concesso premi in forma di azioni a 24 nuovi dipendenti non esecutivi. I premi, che coprono 37.726 azioni ordinarie di Nevro, sono stati assegnati il 7 novembre 2024, nell'ambito del Piano di Premi per Induzione 2023 dell'azienda. Questi premi, approvati dal Comitato per la Compensazione del Consiglio di Amministrazione di Nevro, si matureranno nel corso di un periodo di tre anni, subordinato al mantenimento dell'impiego. I premi sono stati emessi in conformità con la Regola 303A.08 del Manuale delle Aziende Quotabili NYSE come incentivi materiali all'assunzione.
Nevro Corp. (NYSE: NVRO) ha otorgado premios de unidades de acciones restringidas por inducción a 24 nuevos empleados no ejecutivos. Los premios, que cubren 37,726 acciones ordinarias de Nevro, se otorgaron el 7 de noviembre de 2024, bajo el Plan de Premiación por Inducción de 2023 de la compañía. Estos premios, aprobados por el Comité de Compensación de la Junta Directiva de Nevro, se consolidarán a lo largo de un período de tres años, sujeto a continuación del empleo. Los premios se emitieron de acuerdo con la Regla 303A.08 del Manual de Empresas Cotizadas de la NYSE como incentivos materiales para el empleo.
네vro Corp. (NYSE: NVRO)는 24명의 신입 비임원 직원에게 유도 제약 주식 단위 보상을 부여했습니다. 이 보상은 Nevro의 보통주 37,726주를 포함하며, 2024년 11월 7일에 회사의 2023 유도 보상 계획에 따라 부여되었습니다. 이 보상은 Nevro의 이사회의 보상 위원회에서 승인되었으며, 지속적 고용 조건에서 3년 동안 점진적으로 부여될 것입니다. 이 보상은 NYSE 상장 회사 매뉴얼 규칙 303A.08에 따라 고용 유도를 위한 물질적 인센티브로 발행되었습니다.
Nevro Corp. (NYSE: NVRO) a accordé des récompenses en unités d'actions restreintes à 24 nouveaux employés non exécutifs. Ces récompenses, portant sur 37 726 actions ordinaires de Nevro, ont été attribuées le 7 novembre 2024, dans le cadre du Plan de Récompenses par Induction 2023 de l'entreprise. Ces récompenses, approuvées par le Comité de Rémunération du Conseil d'Administration de Nevro, seront acquises sur une période de trois ans, sous réserve d'un emploi continu. Les récompenses ont été émises conformément à la règle 303A.08 du Manuel des Sociétés Côtées NYSE en tant qu'incitations matérielles à l'emploi.
Nevro Corp. (NYSE: NVRO) hat 24 neuen nicht-executive Mitarbeitern Anreize in Form von Restricted Stock Units gewährt. Die Auszeichnungen, die 37.726 Aktien des Stammkapitals von Nevro abdecken, wurden am 7. November 2024 im Rahmen des Unternehmensplans für Anreizvergaben 2023 gewährt. Diese Zuwendungen, die vom Vergütungsausschuss des Vorstands von Nevro genehmigt wurden, unterliegen der Bedingung einer dreijährigen Vesting-Periode bei fortgesetzter Anstellung. Die Auszeichnungen wurden gemäß Regel 303A.08 des NYSE Listing Company Manual als wesentliche Anreize für die Beschäftigung ausgegeben.
- Stock-based compensation structure implemented to attract new talent
- Three-year vesting period promotes employee retention
- Potential shareholder dilution from 37,726 new shares
- Additional stock-based compensation expenses impact financial statements
Each award was granted as a material inducement to employment in accordance with the NYSE Listed Company Manual Rule 303A.08.
Internet Posting of Information
Nevro routinely posts information that may be important to investors in the "Investor Relations" section of its website at www.nevro.com. The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.
About Nevro
Headquartered in
Senza®, Senza II®, Senza Omnia™, and HFX iQ are the only SCS systems that deliver Nevro's proprietary 10 kHz Therapy. Nevro's unique support services provide every patient with an HFX Coach™ throughout their pain relief journey and every physician with Nevrocloud™ insights for enhanced patient and practice management.
SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm, HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access logo, HFX COACH, the HFX Coach logo, Nevrocloud, RELIEF MULTIPLIED, HFX AdaptivAI, the X logo, NEVRO, and the NEVRO logo are trademarks or registered trademarks of Nevro Corp. Patents covering Senza HFX iQ and other Nevro products are listed at Nevro.com/patents. Bluetooth® and the Bluetooth symbol are registered trademarks of their respective owners.
To learn more about Nevro, connect with us on LinkedIn, X, Facebook, and Instagram.
Investor and Media Contact:
Angie McCabe
Vice President, Investor Relations & Corporate Communications
angeline.mccabe@nevro.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/nevro-announces-new-employee-inducement-grants-under-nyse-rule-303a08-302306326.html
SOURCE Nevro Corp.
FAQ
How many shares were granted in Nevro's (NVRO) November 2024 inducement awards?
What is the vesting period for Nevro's (NVRO) November 2024 inducement grants?
How many employees received Nevro's (NVRO) November 2024 inducement grants?
Under which plan were Nevro's (NVRO) November 2024 inducement grants issued?
